Dr William Paul Biddle, MD - Medicare Cardiovascular Disease (cardiology) in Omaha, NE

Dr William Paul Biddle, MD is a medicare enrolled "Internal Medicine - Interventional Cardiology" physician in Omaha, Nebraska. He went to University Of Tennessee, Hsc, College Of Medicine and graduated in 1984 and has 40 years of diverse experience with area of expertise as Cardiovascular Disease (cardiology). He is a member of the group practice Unmc Physicians and his current practice location is Emile 42nd St, Omaha, Nebraska. You can reach out to his office (for appointments etc.) via phone at (402) 559-8888.

Dr William Paul Biddle is licensed to practice in Nebraska (license number 18845) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1538273255.

Contact Information

Dr William Paul Biddle, MD
Emile 42nd St,
Omaha, NE 68198-2027
(402) 559-8888
(402) 559-3060



Physician's Profile

Full NameDr William Paul Biddle
GenderMale
SpecialityCardiovascular Disease (cardiology)
Experience40 Years
LocationEmile 42nd St, Omaha, Nebraska
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr William Paul Biddle attended and graduated from University Of Tennessee, Hsc, College Of Medicine in 1984
  NPI Data:
  • NPI Number: 1538273255
  • Provider Enumeration Date: 08/19/2006
  • Last Update Date: 07/14/2017
  Medicare PECOS Information:
  • PECOS PAC ID: 8628165602
  • Enrollment ID: I20100520000767

Medical Identifiers

Medical identifiers for Dr William Paul Biddle such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1538273255NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RC0000XInternal Medicine - Cardiovascular Disease 18845 (Nebraska)Secondary
207RI0011XInternal Medicine - Interventional Cardiology 18845 (Nebraska)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
The Nebraska Medical CenterOmaha, NEHospital
Crawford County Memorial HospitalDenison, IAHospital
Bellevue Medical CenterBellevue, NEHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Unmc Physicians60027283911320

News Archive

Altheus Therapeutics completes enrollment for Phase 2 trial of Zoenasa Rectal Gel for distal ulcerative colitis

Altheus Therapeutics, Inc., announced that it has completed enrollment for ZA201, a 6-week, double-blind, active-controlled Phase 2 clinical trial of the efficacy and safety of Zoenasa Rectal Gel in approximately 120 adult patients with left-sided, or distal, ulcerative colitis. Topline results are expected in to be available in March or early April.

Researchers pioneer simple but revolutionary approach to early Alzheimer's diagnosis

A simple but revolutionary approach to early Alzheimer's diagnosis is being pioneered by researchers through an initiative that could pave the way for improved outcomes for individuals who develop the disease in the future.

Dual therapy improves cardiac outcomes in pediatric patients suffering from MIS-C

A recent study by a multidisciplinary team of cardiologists and infectious disease specialists at Children's Hospital Colorado (Children's Colorado) found that pediatric patients suffering from Multisystem Inflammatory Syndrome (MIS-C) who received initial, intensified therapy consisting of intravenous immunoglobulin (IVIG) plus Infliximab had improved cardiac outcomes versus those who received IVIG alone.

Portable device for point-of-care diagnostic testing to detect cancer at earliest stages

Reaching a clinic in time to receive an early diagnosis for cancer - when the disease is most treatable - is a global problem. And now a team of Chinese researchers proposes a global solution: have a user-friendly diagnostic device travel to the patient, anywhere in the world.

BioVex commences dosing in Phase 1 study of ImmunoVEX live attenuated genital herpes vaccine

BioVex Inc, a private biotechnology company developing new generation biologics for the treatment of cancer and prevention of infectious disease, announced today that the first subject had been dosed in the Phase 1 study of its live attenuated genital herpes vaccine, ImmunoVEXHSV2. The Phase 1 study is an open label ascending dose trial, assessing safety and immune response in healthy volunteers. The study is taking place in the UK at the Chelsea and Westminster Hospital in London and will involve up to 42 already identified subjects.

Read more Medical News

› Verified 7 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr William Paul Biddle allows following entities to bill medicare on his behalf.
Entity NameUnmc Physicians
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1417912114
PECOS PAC ID: 6002728391
Enrollment ID: O20031104000664

News Archive

Altheus Therapeutics completes enrollment for Phase 2 trial of Zoenasa Rectal Gel for distal ulcerative colitis

Altheus Therapeutics, Inc., announced that it has completed enrollment for ZA201, a 6-week, double-blind, active-controlled Phase 2 clinical trial of the efficacy and safety of Zoenasa Rectal Gel in approximately 120 adult patients with left-sided, or distal, ulcerative colitis. Topline results are expected in to be available in March or early April.

Researchers pioneer simple but revolutionary approach to early Alzheimer's diagnosis

A simple but revolutionary approach to early Alzheimer's diagnosis is being pioneered by researchers through an initiative that could pave the way for improved outcomes for individuals who develop the disease in the future.

Dual therapy improves cardiac outcomes in pediatric patients suffering from MIS-C

A recent study by a multidisciplinary team of cardiologists and infectious disease specialists at Children's Hospital Colorado (Children's Colorado) found that pediatric patients suffering from Multisystem Inflammatory Syndrome (MIS-C) who received initial, intensified therapy consisting of intravenous immunoglobulin (IVIG) plus Infliximab had improved cardiac outcomes versus those who received IVIG alone.

Portable device for point-of-care diagnostic testing to detect cancer at earliest stages

Reaching a clinic in time to receive an early diagnosis for cancer - when the disease is most treatable - is a global problem. And now a team of Chinese researchers proposes a global solution: have a user-friendly diagnostic device travel to the patient, anywhere in the world.

BioVex commences dosing in Phase 1 study of ImmunoVEX live attenuated genital herpes vaccine

BioVex Inc, a private biotechnology company developing new generation biologics for the treatment of cancer and prevention of infectious disease, announced today that the first subject had been dosed in the Phase 1 study of its live attenuated genital herpes vaccine, ImmunoVEXHSV2. The Phase 1 study is an open label ascending dose trial, assessing safety and immune response in healthy volunteers. The study is taking place in the UK at the Chelsea and Westminster Hospital in London and will involve up to 42 already identified subjects.

Read more Medical News

› Verified 7 days ago

Entity NameFranciscan Care Services Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1043224975
PECOS PAC ID: 4284624909
Enrollment ID: O20040514000822

News Archive

Altheus Therapeutics completes enrollment for Phase 2 trial of Zoenasa Rectal Gel for distal ulcerative colitis

Altheus Therapeutics, Inc., announced that it has completed enrollment for ZA201, a 6-week, double-blind, active-controlled Phase 2 clinical trial of the efficacy and safety of Zoenasa Rectal Gel in approximately 120 adult patients with left-sided, or distal, ulcerative colitis. Topline results are expected in to be available in March or early April.

Researchers pioneer simple but revolutionary approach to early Alzheimer's diagnosis

A simple but revolutionary approach to early Alzheimer's diagnosis is being pioneered by researchers through an initiative that could pave the way for improved outcomes for individuals who develop the disease in the future.

Dual therapy improves cardiac outcomes in pediatric patients suffering from MIS-C

A recent study by a multidisciplinary team of cardiologists and infectious disease specialists at Children's Hospital Colorado (Children's Colorado) found that pediatric patients suffering from Multisystem Inflammatory Syndrome (MIS-C) who received initial, intensified therapy consisting of intravenous immunoglobulin (IVIG) plus Infliximab had improved cardiac outcomes versus those who received IVIG alone.

Portable device for point-of-care diagnostic testing to detect cancer at earliest stages

Reaching a clinic in time to receive an early diagnosis for cancer - when the disease is most treatable - is a global problem. And now a team of Chinese researchers proposes a global solution: have a user-friendly diagnostic device travel to the patient, anywhere in the world.

BioVex commences dosing in Phase 1 study of ImmunoVEX live attenuated genital herpes vaccine

BioVex Inc, a private biotechnology company developing new generation biologics for the treatment of cancer and prevention of infectious disease, announced today that the first subject had been dosed in the Phase 1 study of its live attenuated genital herpes vaccine, ImmunoVEXHSV2. The Phase 1 study is an open label ascending dose trial, assessing safety and immune response in healthy volunteers. The study is taking place in the UK at the Chelsea and Westminster Hospital in London and will involve up to 42 already identified subjects.

Read more Medical News

› Verified 7 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr William Paul Biddle is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr William Paul Biddle, MD
988102 Nebraska Medical Ctr,
Omaha, NE 68198-8102

Ph: () -
Dr William Paul Biddle, MD
Emile 42nd St,
Omaha, NE 68198-2027

Ph: (402) 559-8888

News Archive

Altheus Therapeutics completes enrollment for Phase 2 trial of Zoenasa Rectal Gel for distal ulcerative colitis

Altheus Therapeutics, Inc., announced that it has completed enrollment for ZA201, a 6-week, double-blind, active-controlled Phase 2 clinical trial of the efficacy and safety of Zoenasa Rectal Gel in approximately 120 adult patients with left-sided, or distal, ulcerative colitis. Topline results are expected in to be available in March or early April.

Researchers pioneer simple but revolutionary approach to early Alzheimer's diagnosis

A simple but revolutionary approach to early Alzheimer's diagnosis is being pioneered by researchers through an initiative that could pave the way for improved outcomes for individuals who develop the disease in the future.

Dual therapy improves cardiac outcomes in pediatric patients suffering from MIS-C

A recent study by a multidisciplinary team of cardiologists and infectious disease specialists at Children's Hospital Colorado (Children's Colorado) found that pediatric patients suffering from Multisystem Inflammatory Syndrome (MIS-C) who received initial, intensified therapy consisting of intravenous immunoglobulin (IVIG) plus Infliximab had improved cardiac outcomes versus those who received IVIG alone.

Portable device for point-of-care diagnostic testing to detect cancer at earliest stages

Reaching a clinic in time to receive an early diagnosis for cancer - when the disease is most treatable - is a global problem. And now a team of Chinese researchers proposes a global solution: have a user-friendly diagnostic device travel to the patient, anywhere in the world.

BioVex commences dosing in Phase 1 study of ImmunoVEX live attenuated genital herpes vaccine

BioVex Inc, a private biotechnology company developing new generation biologics for the treatment of cancer and prevention of infectious disease, announced today that the first subject had been dosed in the Phase 1 study of its live attenuated genital herpes vaccine, ImmunoVEXHSV2. The Phase 1 study is an open label ascending dose trial, assessing safety and immune response in healthy volunteers. The study is taking place in the UK at the Chelsea and Westminster Hospital in London and will involve up to 42 already identified subjects.

Read more News

› Verified 7 days ago


Internal Medicine Doctors in Omaha, NE

Dr. Marium Ilahi, MD
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 7710 Mercy Rd, Suite 426, Omaha, NE 68124
Phone: 402-717-3636    Fax: 402-717-5050
Dr. Vidhya Murukesan, M.B.,B.S
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 601 N 30th St, Creighton University - Gme, Omaha, NE 68131
Phone: 402-280-5250    
Matthew John Kapalis, DO
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 7500 Mercy Rd, Omaha, NE 68124
Phone: 402-398-6255    Fax: 402-398-6255
Abbie K Ray-deering, MD
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 17500 Burke St, Omaha, NE 68118
Phone: 402-354-2360    Fax: 402-354-2440
Dr. Elizabeth Rini Schnaubelt, M.D.
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: Emile @ 42nd St, Omaha, NE 68198
Phone: 402-559-4015    Fax: 402-559-5581
Sarah Kesterson, M.D.
Internal Medicine
Medicare: Medicare Enrolled
Practice Location: 982055 Nebraska Medical Ctr, Omaha, NE 68198
Phone: 402-559-7792    Fax: 402-559-9385
Dr. Lauren C Licitra, M.D.
Internal Medicine
Medicare: Medicare Enrolled
Practice Location: 42 Nd And Emile St, Omaha, NE 68198
Phone: 402-559-4000    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.